The proposed acquisition of Phytoatomy Private Limited is still under process and has not been completed as on date. The Company has not acquired control or shareholding in the Company.
Awaiting price reaction for this filing.
Radha Madhav Corporation Ltd (RMCL) has clarified that its proposed acquisition of a majority stake in Phytoatomy Private Limited, first announced on November 4, 2023, is still under process and has not been completed as of January 23, 2026. The company stated it has not yet acquired any control or shareholding in Phytoatomy. This filing appears to be a clarification, likely issued in response to market speculation or a stock exchange query about the deal's progress. The acquisition has now been pending for over two years since the original intimation, with no completion in sight.
For shareholders, this means the long-anticipated acquisition remains pending with no clear timeline, which may dampen investor expectations if the deal was factored into the stock's valuation. The prolonged uncertainty could weigh on sentiment until further clarity emerges.